Source: Health Canada shortage reports · Updated Jul 28, 2026
Some Nifedipine products are in shortage in Canada (3 of 16 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A calcium channel blocker used to treat high blood pressure and chest pain (angina).
Products affected
3 / 16
In shortage since
Mar 10, 2017
Reports on file
61
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
DIN 02349167 · ended Nov 7, 2023 · Disruption of the manufacture of the drug.
Avoided
NIFEDIPINE
5MG · CAPSULE · AA PHARMA INC
DIN 00725110 · ended Jul 27, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
10MG · CAPSULE · AA PHARMA INC
DIN 00755907 · ended Jul 27, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
5MG · CAPSULE · AA PHARMA INC
DIN 00725110 · ended May 30, 2023 · Disruption of the manufacture of the drug.
Resolved
NIFEDIPINE
10MG · CAPSULE · AA PHARMA INC
DIN 00755907 · ended Feb 10, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Nifedipine is currently affected by 3 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Nifedipine is classified under “SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.” (ATC C08CA).
Recent changes
Jul 28, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 11, 2026
Jul 20, 2026
New report filed
Common questions
What is Nifedipine used for?
A calcium channel blocker used to treat high blood pressure and chest pain (angina).
When will Nifedipine be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Nifedipine in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.